Friday, June 26, 2009

Market outlook 26th june

Strong & Weak  futures
 
This is list of 10 strong futures: JP Hydro, Aurobindo Pharma, Edu Comp, Indus Ind Bank, Central Bank, LIC Housing Finance, Biocon, IDBI, IVRCL Infra & Tech M.  And this is list of 10  Weak futures: Nation Aluminium, GMR Infra, Escorts, Net Work 18, Amtek Auto, NDTV, Bharat Forge, Orchid Chem, Jet Airways & TCS.
 

 
Nifty is in Down Trend.

 
NIFTY FUTURES (F & O):  
Above 4281 level, expect short covering up to 4327-4329 zone and thereafter expect a jump up to 4373-4375 zone by non-stop.
Support at 4250 level. Below this level, selling may continue up to 4228-4230 zone by non-stop.

Buy if touches 4182-4184 zone. Stop Loss at 4136-4138 zone.

On Positive Side, cross above 4419-4421 zone can take it up to 4465-4467 zone. Supply expected at around this zone and have caution.
 
Short-Term Investors:  
Bullish Trend. 3 closes above 4273 level, it can zoom up to 4837 level by non-stop.
Already SL triggered. 3 closes below 4273 level, it can tumble up to 3991 level by non-stop.
 
BSE SENSEX:  
Higher opening expected. Recovery should start. 
Short-Term Investors:
 
Short-Term trend is Bearish and target at around 12478 level on down side.
Maintain a Stop Loss at 14931 level for your short positions too.
Already SL triggered.
 
INVESTMENT BUY:
Buy ICICI BANK (NSE Cash) 
Good for 1 Day, 1 Month & 3 Months Holding.
Profit booking expected within a week.

Rally to continue within 1 year also, but bulls will try to offload their positions and have caution.
 
Buy STERLITE INDS (I) (NSE Cash) 
Good for 1 Day, 1 Month, 3 Months & 1 Year Holding.

Global Cues & Rupee  
The Dow Jones Industrial Average closed at 8,472.40. Up by 172.54 points.
The Broader S&P 500 closed at 920.26. Up by 19.32 points.
The Nasdaq Composite Index closed at 1,829.54. Up by 37.20 points.
The partially convertible rupee ended at 48.595/605 per dollar on yesterday, below Wednesday's close of 48.56/57.
 
MARKET BUZZ:
 
(May not be useful for day-traders.)

Wyeth Limited

BSE 500095

CMP Rs 605.65
 
 
Trigger Points
Global Merger With Pfizer

Stock should rise in value alongside Pfizer India
 

Financials Rs/Crore                               FY09              FY08
Description
Revenues                                                    402              362
Net Profit                                                     99.6              81.4
Equity Capital                                             22.7             22.7
EPS                                                        Rs43.87            35.86
Dividend                                     Rs/Share32.5             30
                                                                     PE13
12 Month PO                                          Rs 700

(Some forward looking statements on projections, estimates, expectations & outlook are included to enable a better comprehension of the Company prospects. Actual results may, however, differ materially from those stated on account of factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Company conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.)
 

Profit booking expected within a week.
 
--
Arvind Parekh
+ 91 98432 32381